![Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational study - The Lancet Global Health Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational study - The Lancet Global Health](https://www.thelancet.com/cms/asset/74566dd8-e515-4af0-90a8-9543a6b89f3a/gr1.gif)
Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational study - The Lancet Global Health
Recombivax HB, Hepatitis B Vaccine (Recombinant) Pediatric Formulation, 0.5 mL | Smithsonian Institution
![Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study | BMC Public Health | Full Text Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study | BMC Public Health | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2458-14-991/MediaObjects/12889_2014_Article_7304_Fig1_HTML.jpg)
Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study | BMC Public Health | Full Text
![Hepatitis B vaccine (Engrix B 10 microgram)is also available and three... | Download Scientific Diagram Hepatitis B vaccine (Engrix B 10 microgram)is also available and three... | Download Scientific Diagram](https://www.researchgate.net/publication/333784341/figure/tbl2/AS:769737097224195@1560531033918/Hepatitis-B-vaccine-Engrix-B-10-microgramis-also-available-and-three-doses-are.png)
Hepatitis B vaccine (Engrix B 10 microgram)is also available and three... | Download Scientific Diagram
![Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60–70 years - ScienceDirect Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60–70 years - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0264410X19310448-ga1.jpg)
Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60–70 years - ScienceDirect
![Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial - The Lancet Infectious Diseases Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/91dbf75b-2288-4086-9df9-adddee7ae55e/gr1_lrg.jpg)
Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial - The Lancet Infectious Diseases
![Nabi-HB® [Hepatitis B Immune Globulin (Human)] | Acute Exposure to HBV :: ADMA Biologics, Inc. - Nabi-HB Nabi-HB® [Hepatitis B Immune Globulin (Human)] | Acute Exposure to HBV :: ADMA Biologics, Inc. - Nabi-HB](https://s3.amazonaws.com/content.stockpr.com/nabihb/files/pages/nabi-hb-for-general-population/threat-of-hbv/percents.jpg)